Variant report
Variant | esv1002545 |
---|---|
Chromosome Location | chr6:66258736-66262125 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1331197 | chr6:66258778-66258779 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs530909742 | chr6:66258779-66258780 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs550703996 | chr6:66258805-66258806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570472322 | chr6:66258827-66258828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535147802 | chr6:66258860-66258861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs544205298 | chr6:66258900-66258901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs151132398 | chr6:66258907-66258908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs553605179 | chr6:66258919-66258920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567069581 | chr6:66258922-66258923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536182899 | chr6:66258929-66258930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs193172846 | chr6:66258947-66258948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575955089 | chr6:66258949-66258950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs543532222 | chr6:66258950-66258951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs9363392 | chr6:66258951-66258952 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs576858578 | chr6:66259016-66259017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140109105 | chr6:66259017-66259018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559564175 | chr6:66259042-66259043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573037084 | chr6:66259079-66259080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542154329 | chr6:66259108-66259109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs35788927 | chr6:66259180-66259181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574305760 | chr6:66259187-66259188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200749446 | chr6:66259216-66259217 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs76838586 | chr6:66259218-66259219 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs386702136 | chr6:66259221-66259222 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs369857325 | chr6:66259224-66259225 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145147854 | chr6:66259245-66259246 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs558303330 | chr6:66259259-66259260 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs60828468 | chr6:66259270-66259271 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs533123943 | chr6:66259277-66259278 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7767793 | chr6:66259309-66259310 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs185307743 | chr6:66259331-66259332 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs6937452 | chr6:66259358-66259359 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs549689255 | chr6:66259374-66259375 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs371808890 | chr6:66259376-66259377 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs6937478 | chr6:66259410-66259411 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs6455046 | chr6:66259421-66259422 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs190549696 | chr6:66259437-66259438 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs182331613 | chr6:66259455-66259456 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs6932966 | chr6:66259508-66259509 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs566792726 | chr6:66259513-66259514 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs6909711 | chr6:66259537-66259538 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs6455047 | chr6:66259546-66259547 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs116495221 | chr6:66259615-66259616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs139032003 | chr6:66259671-66259672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs9354264 | chr6:66259713-66259714 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs183751399 | chr6:66259741-66259742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs369809047 | chr6:66259742-66259743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs140656984 | chr6:66259751-66259752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547119691 | chr6:66259757-66259758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs560275365 | chr6:66259761-66259762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Dyslexia | 22102821 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Retinitis pigmentosa | 21519034 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:66257000-66258800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr6:66257400-66260000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr6:66258400-66259000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr6:66258600-66260000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr6:66258800-66259200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr6:66258800-66260000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr6:66259200-66259600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr6:66259600-66259800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr6:66259800-66267200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr6:66260000-66262200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |